首页 › 基金 › EQT Fund Management S.a r.l. › OCS
EQT Fund Management S.a r.l. 对 OCS 的持仓历史
Oculis Holding AG · 医疗保健
EQT Fund Management S.a r.l. 在 Q3 2026 的 13F 申报中披露持有 OCS(Oculis Holding AG)6,950,294 股,市值约 US$64.9M,约占其申报组合的 6.85%,在其申报持仓中市值排名第 3 位。 EQT Fund Management S.a r.l. 最近 5 个申报季度中有 5 个季度披露了 OCS 持仓,最早可追溯至 Q3 2025。
最后更新: 2026-11-12 · 来源: SEC EDGAR Form 13F-HR
EQT Fund Management S.a r.l. 对 OCS 的持仓演变
EQT Fund Management S.a r.l. 于 Q3 2025 首次披露 OCS 持仓:5,900,294 股(约 US$103.7M)。 该持仓在 Q1 2026 达到峰值 5,900,294 股,市值约 US$156.9M。 在 5 次申报中,EQT Fund Management S.a r.l. 1 次增持、0 次减持、3 次保持不变。 最近一期申报(Q3 2026)显示持股 6,950,294 股、市值约 US$64.9M。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2025 | 5.90M | $103.73M | 新进 |
| Q4 2025 | 5.90M | $117.83M | 持有 |
| Q1 2026 | 5.90M | $156.89M | 持有 |
| Q2 2026 | 6.95M | $96.40M | 增持 |
| Q3 2026 | 6.95M | $64.92M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 OCS 与 13F 数据
OCS(Oculis Holding AG)属于医疗保健行业。我们追踪的基金中还有 64 只申报持有 OCS,申报仓位最大的包括:Gildi - lifeyrissjodur (US$64.3M), Pivotal bioVenture Partners Investment Advisor LLC (US$20.9M), Saturn V Capital Management LP (US$9.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 OCS 的基金
- Gildi - lifeyrissjodur 2.43M 股 · $64.32M · Q1 2026
- Pivotal bioVenture Partners Investment Advisor LLC 1.51M 股 · $20.89M · Q2 2026
- Saturn V Capital Management LP 684.88K 股 · $9.50M · Q2 2026
- SR ONE CAPITAL MANAGEMENT, LP 641.02K 股 · $8.89M · Q2 2026
- SYQUANT CAPITAL SAS 375.00K 股 · $5.20M · Q2 2026
- Nan Fung Group Holdings Ltd 300.56K 股 · $4.17M · Q2 2026
- Marble Bar Asset Management LLP 14.81K 股 · $205.36K · Q2 2026
- DUPONT CAPITAL MANAGEMENT CORP 4 股 · $55.00K · Q2 2026
更多关于 EQT Fund Management S.a r.l.
常见问题
How long has EQT Fund Management S.a r.l. held OCS?
EQT Fund Management S.a r.l. has disclosed OCS holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
What is EQT Fund Management S.a r.l.'s current position in OCS?
As of Q3 2026, EQT Fund Management S.a r.l. holds 6.95M shares of OCS (Oculis Holding AG), valued at $64.92M, representing 6.85% of its reported portfolio and ranking #3.
Has EQT Fund Management S.a r.l. been buying or selling OCS?
In the latest 13F filing (Q3 2026), EQT Fund Management S.a r.l. held unchanged its position in OCS. The position peaked in Q1 2026 at 5.90M shares.
Which other funds hold OCS?
Other major institutional holders of OCS include Gildi - lifeyrissjodur, Pivotal bioVenture Partners Investment Advisor LLC, Saturn V Capital Management LP, among 64 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.